uniQure (QURE) Work In Process (2022 - 2024)
uniQure (QURE) posted quarterly Work In Process of $1.3 million for Q1 2024, down 67.36% quarter-over-quarter from $4.1 million in Q4 2023.
Analysis
uniQure (QURE) Work In Process (2022 - 2024) Analysis & Trends
uniQure's Work In Process history runs 3 years deep, the most recent figure standing at $1.3 million for Q1 2024.
- In Q1 2024, Work In Process changed N/A year-over-year to $1.3 million; the TTM figure through Mar 2024 stood at $1.3 million (changed N/A YoY), while the FY2023 annual figure was $4.1 million, up 119.26% from the prior year.
- Work In Process for Q1 2024 stood at $1.3 million, down from $4.1 million in the prior quarter.
- The five-year high for Work In Process was $6.6 million in Q3 2023, with the low at $1.3 million in Q1 2024.
- The 3-year median for Work In Process is $3.1 million (2022), against an average of $3.4 million.
- Peak annual rise in Work In Process reached 202.89% in 2023, while the deepest fall reached 119.26% in 2023.
- uniQure's Work In Process stood at $1.9 million in 2022, then soared by 119.26% to $4.1 million in 2023, then plunged by 67.36% to $1.3 million in 2024.
- Business Quant data shows QURE's Work In Process at $1.3 million in Q1 2024, $4.1 million in Q4 2023, and $6.6 million in Q3 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | uniQure | 2.95 Bn | 2.95 Bn | 5.49 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2024 | 1.34 Mn |
| Dec 31, 2023 | 4.11 Mn |
| Sep 30, 2023 | 6.60 Mn |
| Jun 30, 2023 | 4.06 Mn |
| Dec 31, 2022 | 1.87 Mn |
| Sep 30, 2022 | 2.18 Mn |